Literature DB >> 30363844

Continuous Subcutaneous Apomorphine Infusion Improves Severe Restless Legs Syndrome.

Thomas Müller1, Marion Marg1, Hartmut Rothe1, Matthias Küchler1.   

Abstract

Entities:  

Keywords:  apomorphine; restless legs syndrome

Year:  2014        PMID： 30363844      PMCID： PMC6182991          DOI： 10.1002/mdc3.12039

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN： 2330-1619


× No keyword cloud information.
  5 in total

1.  Acute low single dose of apomorphine reduces periodic limb movements but has no significant effect on sleep arousals: a preliminary report.

Authors:  José Haba-Rubio; Luc Staner; Françoise Cornette; Erik Lainey; Rémy Luthringer; Jean Krieger; Jean P Macher
Journal:  Neurophysiol Clin       Date:  2003-09       Impact factor: 3.734

2.  Treatment of restless legs syndrome with subcutaneous apomorphine in a patient with short bowel syndrome.

Authors:  T Tings; G Stiens; W Paulus; C Trenkwalder; S Happe
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

3.  Apomorphine in idiopathic restless legs syndrome: an exploratory study.

Authors:  G G Tribl; T Sycha; N Kotzailias; J Zeitlhofer; E Auff
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-02       Impact factor: 10.154

4.  Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome.

Authors:  I Reuter; C M Ellis; K Ray Chaudhuri
Journal:  Acta Neurol Scand       Date:  1999-09       Impact factor: 3.209

5.  Growth hormone response to low-dose apomorphine in restless legs syndrome.

Authors:  Svenja Happe; Cornelius G Bachmann; Kathrin Helmschmied; Karin Neubert; Wolfgang Wuttke; Walter Paulus; Claudia Trenkwalder
Journal:  Growth Horm IGF Res       Date:  2007-05-18       Impact factor: 2.372
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.